| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9675 |
| Human Intestinal Absorption | HIA+ | 0.7488 |
| Caco-2 Permeability | Caco2- | 0.6330 |
| P-glycoprotein Substrate | Non-substrate | 0.9142 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9238 |
| Non-inhibitor | 0.9906 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9526 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5303 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8775 |
| CYP450 2D6 Substrate | Non-substrate | 0.8242 |
| CYP450 3A4 Substrate | Non-substrate | 0.7069 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7947 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7720 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9183 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7729 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9783 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9607 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7987 |
| Non-inhibitor | 0.9475 |
| AMES Toxicity | Non AMES toxic | 0.5815 |
| Carcinogens | Carcinogens | 0.8218 |
| Fish Toxicity | Low FHMT | 0.6442 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7756 |
| Honey Bee Toxicity | High HBT | 0.7943 |
| Biodegradation | Ready biodegradable | 0.9437 |
| Acute Oral Toxicity | III | 0.6112 |
| Carcinogenicity (Three-class) | Non-required | 0.6684 |